StockNews.com Initiates Coverage on Veradigm (NASDAQ:MDRX)

Equities researchers at StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX) in a research note issued on Thursday. The firm set a “hold” rating on the software maker’s stock.

Veradigm Price Performance

Veradigm stock opened at $9.05 on Thursday. The company’s 50-day moving average price is $9.55 and its two-hundred day moving average price is $9.10. Veradigm has a 52 week low of $5.01 and a 52 week high of $13.62.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Innealta Capital LLC acquired a new position in shares of Veradigm in the second quarter worth about $38,000. Meadow Creek Wealth Advisors LLC acquired a new stake in shares of Veradigm during the first quarter worth approximately $83,000. Tyro Capital Management LLC bought a new position in Veradigm during the first quarter valued at approximately $9,055,000. Goldman Sachs Group Inc. raised its position in Veradigm by 6.6% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock valued at $16,749,000 after acquiring an additional 99,528 shares in the last quarter. Finally, Vanguard Group Inc. raised its position in Veradigm by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock valued at $149,754,000 after acquiring an additional 95,291 shares in the last quarter.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.